Anafranil and Eye disorder - a phase IV clinical study of FDA data

Summary:

Eye disorder is reported as a side effect among people who take Anafranil (clomipramine hydrochloride), especially for people who are male, 60+ old, also take Remeron, and have Calcinosis.

The phase IV clinical study analyzes which people have Eye disorder when taking Anafranil. It is created by eHealthMe based on reports of 6,081 people who have side effects when taking Anafranil from the FDA, and is updated regularly.

What is Anafranil?

Anafranil has active ingredients of clomipramine hydrochloride. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 6,304 Anafranil users. Check the latest studies of Anafranil.

What is Eye disorder?

Eye disorder is found to be associated with 1,352 drugs and 1,452 conditions by eHealthMe. Check the latest studies of Eye disorder.

On Jul, 05, 2026

6,081 people reported to have side effects when taking Anafranil.
Among them, 13 people (0.21%) have Eye disorder.

Among these 13 people:

What is the gender of people who have Eye disorder when taking Anafranil? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Eye disorder when taking Anafranil? *

What are other drugs people take besides Anafranil? *

What are other side effects people have besides Eye disorder? *

Dyspnea (difficult or laboured breathing): 5 people, 38.46%
Nausea (feeling of having an urge to vomit): 5 people, 38.46%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 3 people, 23.08%
Pericarditis (inflammation of the pericardium): 3 people, 23.08%
Pneumonia: 3 people, 23.08%
Quality Of Life Decreased: 3 people, 23.08%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 3 people, 23.08%
Chest Pain: 3 people, 23.08%
Blindness: 3 people, 23.08%
Haematemesis (vomiting of blood): 3 people, 23.08%

What are the existing conditions these people have? *

Spinal Column Stenosis (narrowing of spinal column): 3 people, 23.08%
Joint Deposit (deposit in joint): 3 people, 23.08%
Calcinosis (calcium deposits in any soft tissue): 3 people, 23.08%
Parkinson's Disease: 2 people, 15.38%
Insomnia (sleeplessness): 2 people, 15.38%
Headache (pain in head): 2 people, 15.38%
Emotional Disorder: 2 people, 15.38%
Dry Eyes (lack of adequate tears): 2 people, 15.38%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 15.38%
Compulsions (performing an act persistently and repetitively): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Anafranil and have Eye disorder?

- Check whether Eye disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anafranil:

Anafranil (6,304 reports)

Eye disorder treatments and more:

Eye disorder (40,666 reports)

Browse all side effects of Anafranil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye disorder:

Eye disorder (1,352 drugs)

Browse all the conditions that are associated with Eye disorder:

Eye disorder (1,452 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clomipramine hydrochloride (the active ingredients of Anafranil) and Anafranil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.